Ann: Patrys 2014 AGM Presentation, page-67

When it becomes apparent enough to BIG PHARMA that approvals will be granted they will make offers, probably very large offers. In the event that the controlling shareholders don't want to sell then Patrys becomes a manufacturer and seller of it's own products which it has been stipulated could be as high as 33% of the melanoma (and other cancers) market stated to be ~ $US3 billion per year and growing. Interesting to see that in 2014 ~ 500 million Patrys shares (out of ~670 million ) were traded but the top 20's holdings didn't appear to change except that one of them bought more. Happy Xmas.